BioAge Labs, Inc. (NASDAQ:BIOA) Financings
Financings
| Raise | Date |
|---|---|
| Public offering of shares of common stock Made bigger: about US$115M · US$19.5 a share · Goldman Sachs & Co. LLC +2 Dealers: Goldman Sachs & Co. LLC (co-lead), Piper Sandler (co-lead), Citigroup (co-lead) Use of proceeds: R&D, clinical and manufacturing of product candidates incl. BGE-102, NLRP3 and APJ programs; working capital, capex, debt reduction, general corporate purposes | Jan 22, 2026 |